Radiolabeling Method: Core/Surface Labeling, Chemical and Physical Labeling View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2018-05-26

AUTHORS

Dong Soo Lee , Minseok Suh , Yun-Sang Lee

ABSTRACT

Radiolabeled nanomaterials can be used for diagnosis, therapy and theranostics of certain diseases. The core concept of radionanomedicine relies on efficient and reliable radiolabeling methods, to bind appropriate isotope with well-functionalized nanoparticles (NPs), and the use of tracer amounts of radiolabeled NPs. In this chapter, we focused on the three issues of producing radiolabeled NPs: choosing appropriate radionuclides for labeling, construction of well-functionalized NPs with surface modification and different labeling methods of NPs with radionuclides. Firstly, choosing ideal isotope starts from understanding the characteristics of each isotopes, such as half-life, decay energy and availability, and understanding of purpose of the study. Secondly, to increase the specific delivery of NPs to the target tissues while decreasing the nonspecific binding to normal tissues well functionalized NPs are necessary, which can be achieved by surface modification. Especially, micelle encapsulation method is an efficient method for producing multifunctional NPs. Finally, ideal labeling method should be adopted, which should not only be quick, easy, and highly efficient but also should not change the biological properties of target molecules. Both intrinsic and extrinsic radiolabeling methods should be chosen in the base of thorough understanding of pros and cons of each labeling methods. In conclusion, the development of the methods to enable surface labeling with ligands and chelators should be solved first. The development of the imaging methods to track the in vivo administered radiolabeled NPs is the next issue to be addressed. With the improvement of above-mentioned issues, radiolabeled NPs can be successfully translated to clinical use. More... »

PAGES

209-227

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_11

DOI

http://dx.doi.org/10.1007/978-3-319-67720-0_11

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104232709


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "id": "sg:person.015617314175.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suh", 
        "givenName": "Minseok", 
        "id": "sg:person.01167347716.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167347716.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Yun-Sang", 
        "id": "sg:person.01152420166.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152420166.90"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2018-05-26", 
    "datePublishedReg": "2018-05-26", 
    "description": "Radiolabeled nanomaterials can be used for diagnosis, therapy and theranostics of certain diseases. The core concept of radionanomedicine relies on efficient and reliable radiolabeling methods, to bind appropriate isotope with well-functionalized nanoparticles (NPs), and the use of tracer amounts of radiolabeled NPs. In this chapter, we focused on the three issues of producing radiolabeled NPs: choosing appropriate radionuclides for labeling, construction of well-functionalized NPs with surface modification and different labeling methods of NPs with radionuclides. Firstly, choosing ideal isotope starts from understanding the characteristics of each isotopes, such as half-life, decay energy and availability, and understanding of purpose of the study. Secondly, to increase the specific delivery of NPs to the target tissues while decreasing the nonspecific binding to normal tissues well functionalized NPs are necessary, which can be achieved by surface modification. Especially, micelle encapsulation method is an efficient method for producing multifunctional NPs. Finally, ideal labeling method should be adopted, which should not only be quick, easy, and highly efficient but also should not change the biological properties of target molecules. Both intrinsic and extrinsic radiolabeling methods should be chosen in the base of thorough understanding of pros and cons of each labeling methods. In conclusion, the development of the methods to enable surface labeling with ligands and chelators should be solved first. The development of the imaging methods to track the in vivo administered radiolabeled NPs is the next issue to be addressed. With the improvement of above-mentioned issues, radiolabeled NPs can be successfully translated to clinical use.", 
    "editor": [
      {
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-67720-0_11", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-67719-4", 
        "978-3-319-67720-0"
      ], 
      "name": "Radionanomedicine", 
      "type": "Book"
    }, 
    "keywords": [
      "surface modification", 
      "radiolabeling method", 
      "multifunctional nanoparticles", 
      "Radiolabeled nanoparticles", 
      "functionalized nanoparticles", 
      "nanoparticles", 
      "physical labeling", 
      "specific delivery", 
      "encapsulation method", 
      "target molecules", 
      "biological properties", 
      "labeling method", 
      "nanomaterials", 
      "different labeling methods", 
      "theranostics", 
      "efficient method", 
      "understanding of purpose", 
      "target tissues", 
      "appropriate radionuclide", 
      "appropriate isotope", 
      "surface labeling", 
      "modification", 
      "delivery", 
      "method", 
      "chemicals", 
      "properties", 
      "labeling", 
      "issues", 
      "energy", 
      "clinical use", 
      "thorough understanding", 
      "certain diseases", 
      "development", 
      "use", 
      "improvement", 
      "molecules", 
      "vivo", 
      "characteristics", 
      "pros", 
      "relies", 
      "amount", 
      "tissue", 
      "normal tissues", 
      "cons", 
      "chapter", 
      "availability", 
      "concept", 
      "construction", 
      "ligands", 
      "radionuclides", 
      "therapy", 
      "base", 
      "core concepts", 
      "understanding", 
      "purpose", 
      "chelators", 
      "diagnosis", 
      "study", 
      "tracer amounts", 
      "next issue", 
      "isotopes", 
      "disease", 
      "start", 
      "conclusion"
    ], 
    "name": "Radiolabeling Method: Core/Surface Labeling, Chemical and Physical Labeling", 
    "pagination": "209-227", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104232709"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-67720-0_11"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-67720-0_11", 
      "https://app.dimensions.ai/details/publication/pub.1104232709"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-10-01T06:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/chapter/chapter_415.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-67720-0_11"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_11'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_11'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_11'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_11'


 

This table displays all metadata directly associated to this object as RDF triples.

138 TRIPLES      22 PREDICATES      87 URIs      80 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-67720-0_11 schema:about anzsrc-for:03
2 anzsrc-for:0306
3 schema:author N35f565beefc84319bc008024c736e47c
4 schema:datePublished 2018-05-26
5 schema:datePublishedReg 2018-05-26
6 schema:description Radiolabeled nanomaterials can be used for diagnosis, therapy and theranostics of certain diseases. The core concept of radionanomedicine relies on efficient and reliable radiolabeling methods, to bind appropriate isotope with well-functionalized nanoparticles (NPs), and the use of tracer amounts of radiolabeled NPs. In this chapter, we focused on the three issues of producing radiolabeled NPs: choosing appropriate radionuclides for labeling, construction of well-functionalized NPs with surface modification and different labeling methods of NPs with radionuclides. Firstly, choosing ideal isotope starts from understanding the characteristics of each isotopes, such as half-life, decay energy and availability, and understanding of purpose of the study. Secondly, to increase the specific delivery of NPs to the target tissues while decreasing the nonspecific binding to normal tissues well functionalized NPs are necessary, which can be achieved by surface modification. Especially, micelle encapsulation method is an efficient method for producing multifunctional NPs. Finally, ideal labeling method should be adopted, which should not only be quick, easy, and highly efficient but also should not change the biological properties of target molecules. Both intrinsic and extrinsic radiolabeling methods should be chosen in the base of thorough understanding of pros and cons of each labeling methods. In conclusion, the development of the methods to enable surface labeling with ligands and chelators should be solved first. The development of the imaging methods to track the in vivo administered radiolabeled NPs is the next issue to be addressed. With the improvement of above-mentioned issues, radiolabeled NPs can be successfully translated to clinical use.
7 schema:editor N88e206a4721b4494b58f1640e94afe8f
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf Nde60b4a2a9514722a64b97e1af5f4174
11 schema:keywords Radiolabeled nanoparticles
12 amount
13 appropriate isotope
14 appropriate radionuclide
15 availability
16 base
17 biological properties
18 certain diseases
19 chapter
20 characteristics
21 chelators
22 chemicals
23 clinical use
24 concept
25 conclusion
26 cons
27 construction
28 core concepts
29 delivery
30 development
31 diagnosis
32 different labeling methods
33 disease
34 efficient method
35 encapsulation method
36 energy
37 functionalized nanoparticles
38 improvement
39 isotopes
40 issues
41 labeling
42 labeling method
43 ligands
44 method
45 modification
46 molecules
47 multifunctional nanoparticles
48 nanomaterials
49 nanoparticles
50 next issue
51 normal tissues
52 physical labeling
53 properties
54 pros
55 purpose
56 radiolabeling method
57 radionuclides
58 relies
59 specific delivery
60 start
61 study
62 surface labeling
63 surface modification
64 target molecules
65 target tissues
66 theranostics
67 therapy
68 thorough understanding
69 tissue
70 tracer amounts
71 understanding
72 understanding of purpose
73 use
74 vivo
75 schema:name Radiolabeling Method: Core/Surface Labeling, Chemical and Physical Labeling
76 schema:pagination 209-227
77 schema:productId N872eac2bf3974112b3af20876435bbbd
78 Nf247195e247d48518f6d1d0707a35875
79 schema:publisher Ne59a6149735c43b4be244689820c1d61
80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104232709
81 https://doi.org/10.1007/978-3-319-67720-0_11
82 schema:sdDatePublished 2022-10-01T06:58
83 schema:sdLicense https://scigraph.springernature.com/explorer/license/
84 schema:sdPublisher N522c9292dce14a7fbdb86af4cbefeb36
85 schema:url https://doi.org/10.1007/978-3-319-67720-0_11
86 sgo:license sg:explorer/license/
87 sgo:sdDataset chapters
88 rdf:type schema:Chapter
89 N1f87d12a2c6a42ec8e751ea8cae7550c rdf:first sg:person.01167347716.80
90 rdf:rest Ncf15e705d5f34afcbe9e2f217d771782
91 N35f565beefc84319bc008024c736e47c rdf:first sg:person.015617314175.88
92 rdf:rest N1f87d12a2c6a42ec8e751ea8cae7550c
93 N522c9292dce14a7fbdb86af4cbefeb36 schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 N872eac2bf3974112b3af20876435bbbd schema:name dimensions_id
96 schema:value pub.1104232709
97 rdf:type schema:PropertyValue
98 N88e206a4721b4494b58f1640e94afe8f rdf:first Nb3b13f76a8d7476ebecd7c3a1307bf94
99 rdf:rest rdf:nil
100 Nb3b13f76a8d7476ebecd7c3a1307bf94 schema:familyName Lee
101 schema:givenName Dong Soo
102 rdf:type schema:Person
103 Ncf15e705d5f34afcbe9e2f217d771782 rdf:first sg:person.01152420166.90
104 rdf:rest rdf:nil
105 Nde60b4a2a9514722a64b97e1af5f4174 schema:isbn 978-3-319-67719-4
106 978-3-319-67720-0
107 schema:name Radionanomedicine
108 rdf:type schema:Book
109 Ne59a6149735c43b4be244689820c1d61 schema:name Springer Nature
110 rdf:type schema:Organisation
111 Nf247195e247d48518f6d1d0707a35875 schema:name doi
112 schema:value 10.1007/978-3-319-67720-0_11
113 rdf:type schema:PropertyValue
114 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
115 schema:name Chemical Sciences
116 rdf:type schema:DefinedTerm
117 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
118 schema:name Physical Chemistry (incl. Structural)
119 rdf:type schema:DefinedTerm
120 sg:person.01152420166.90 schema:affiliation grid-institutes:grid.31501.36
121 schema:familyName Lee
122 schema:givenName Yun-Sang
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152420166.90
124 rdf:type schema:Person
125 sg:person.01167347716.80 schema:affiliation grid-institutes:grid.31501.36
126 schema:familyName Suh
127 schema:givenName Minseok
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167347716.80
129 rdf:type schema:Person
130 sg:person.015617314175.88 schema:affiliation grid-institutes:grid.31501.36
131 schema:familyName Lee
132 schema:givenName Dong Soo
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88
134 rdf:type schema:Person
135 grid-institutes:grid.31501.36 schema:alternateName Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea
136 schema:name Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea
137 Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea
138 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...